This year, Accelsiors had the unique opportunity to participate in the Festival of Biologics USA, held at the San Diego Convention Center on April 23–24.
With over 1,500 participants and exhibitors from around the world, the Festival was an inspiring experience, offering opportunities for growth, raising Accelsiors’ visibility, and establishing many valuable new connections.
The Festival of Biologics featured a variety of sessions and scheduled meetings with our prospective, current, and former collaborators.
Among the key takeaways were critical discussions on streamlining regulations, particularly for biosimilars and cell and gene therapies, underscoring the growing demand for strong regulatory and strategic support, areas where Accelsiors excels.
Conversations around patient-centric trial designs, decentralized solutions, and real-world evidence strategies further emphasized the need for flexible, specialized CRO partners to navigate complex development pathways.
Most rewarding were the meaningful connections made with biotech start-ups, pharmaceutical leaders, and academic researchers, opening new doors for exciting collaborations. It was clear that CROs with deep expertise, innovation, and flexibility will play a vital role in shaping the future of biologics development.
We would like to extend our thanks to all the people and companies we have had the pleasure of meeting at FOBUSA, and a very special thank you to Terrapinn for making all this possible with organising the event.
Do you want more insights? Check out our white paper: Breaking Barriers in Biosimilars: EMA’s 2025 Tailored Pathway and FDA’s Flexible Framework
